Ironwood Pharmaceuticals | صافي الدخل





صافي الدخل تغيير تاريخ
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Almirall EUR 19.58M 7M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -7.74M 6.4M 2025-09
Ardelyx USD -969K 18.11M 2025-09
Astellas Pharma JPY 100.38B 21.17B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Coherus Biosciences USD -56.57M 5.87M 2025-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Exact Sciences USD -19.59M 18.41M 2025-09
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
MacroGenics USD 16.82M 53.07M 2025-09
Moderna USD -200M 625M 2025-09
Myriad Genetics USD -27.4M 303.1M 2025-09
Pacira USD 5.43M 10.28M 2025-09
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12


Ironwood Pharmaceuticals صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.